Literature DB >> 23257762

[Cognitive impairment and anxiety-depressive disorders in patients with rheumatoid arthritis].

T A Lisitsyna, A E Zeltyn', D Iu Vel'tishchev, O B Kovalevskaia, O F Seravina, D S Novikova, A A Novikov, E N Aleksandrova, V N Krasnov, E L Nasonov.   

Abstract

Data on the prevalence and features of cognitive impairment in patients with rheumatoid arthritis (RA) are presented. Cognitive impairment was noted in 66% of patients, it did not reach the threshold of dementia and met the diagnostic criteria for moderate cognitive impairment. Anxiety-depressive spectrum disorders were found in 94% patients. Cognitive impairment was associated with apathic affect and anxiety-depressive spectrum disorders (depressive episodes, dysthymia, and elevated anxiety). The impairment of thinking was correlated with the high to moderate inflammatory activity including non-joint RA symptoms, higher levels of proinflammatory cytokines and low doses of glucocorticoids. Cognitive impairment was not associated with the duration and character of standard treatment of RA and concomitant cardiovascular diseases.

Entities:  

Mesh:

Year:  2012        PMID: 23257762

Source DB:  PubMed          Journal:  Zh Nevrol Psikhiatr Im S S Korsakova        ISSN: 1997-7298


  1 in total

1.  Risk of developing depressive disorders following rheumatoid arthritis: a nationwide population-based study.

Authors:  Shu-Li Wang; Cheng-Ho Chang; Li-Yu Hu; Shih-Jen Tsai; Albert C Yang; Zi-Hong You
Journal:  PLoS One       Date:  2014-09-16       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.